Personal Genome Diagnostics Appoints Megan Bailey as Chief Executive Officer
BALTIMORE--(BUSINESS WIRE)--Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, appointed Megan Bailey as Chief Executive Officer (CEO), promoted from Chief Commercial Officer (CCO). Bailey succeeds Douglas Ward, who has served as PGDx’s Chief Executive Officer since 2016. “PGDx is at the forefront of cancer genomics with a vision to fundamentally change oncology care by delivering products that enable local precision medicine,” said Luis Diaz, MD, Co-Founder and Chairman, Per